East Coast Railway invites applications for 663 posts in COVID-19 care centres; jobs open for para-medics, pharmacists and attendants

-

East Coast Railway (ECR) has invited online applications for recruitment against 663 vacancies in view of the coronavirus pandemic. These include positions of paramedical staff in COVID-19 care centres, medical departments in Khurda Road (KUR) railway division.

Prototype isolation ward developed by Indian Railways amid coornavirus outbreak. ANI

ECR notice said the positions are to ensure adequate preparedness for the Covid Care Centres in 169 coaches of 17 trains in the medical department of KUR Division. Positions for Para-medical staff, Pharmacists and Dressers/ OTA/ Hospital Attendants on contractual basis are being offered.

A notice has also been issued for the engagement of Contract Medical Practitioners.

Aspirants need to download the form from eastcoastrail.indianrailways.gov.in and send it by email to srdmohkur@gmail.com by 22 May. The forms have to be accompanied by self-attested copies of certificates.

Of the 663 vacancies, 255 are for the posts of Nursing Superintendent, 51 for Pharmacists, 255 for Level-1 Dresser/OTA/Hospital Attendants and 102 for Contract Medical Practitioners.

For Nursing Superintendent, one should be between the age of 20 and 38, while Pharmacists should be between 20 and 35 years. The minimum age for Dresser/OTA/Hospital Attendants candidates is 18 and the maximum 33. The maximum age limit of GDMO candidates is 53 years.

Upper age limit can be relaxed for up to 3 years for OBC candidates and 5 years for SC/ST candidates.

The National Coalfields limited had also recently put out a notification for recruitment of retired staff nurse and lab technicians.

Last week, National Health Mission (NHM) in Arunachal Pradesh invited applications for the post of nurse for COVID-19 duty.

 



from Firstpost India Latest News https://ift.tt/362BlCH
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more